Details zur Publikation

Kategorie Textpublikation
Referenztyp Zeitschriften
DOI 10.1038/s41467-026-76948-9
Lizenz creative commons licence
Titel (primär) CD97/ADGRE5 attenuates the induction of adaptive type 2 immune responses in allergic asthma
Autor Aust, G.; Hoh, A.-L.; Alladina, J.; Smith, N.P.; Höhna, F.; Wang, B.; Kerner, C.; Wagner, M.; Krohn, K.; Pierzchalski, A.; Häussler, N.; Villani, A.C.; Cho, J.L.; Medoff, B.D.; Zenclussen, A.C.; Steinert, M.; Hamann, J.; Quaas, M.; Polte, T.
Quelle Nature Communications
Erscheinungsjahr 2026
Department IMMU
Band/Volume 17
Seite von art. 9226
Sprache englisch
Topic T9 Healthy Planet
Supplements Supplement 1
Supplement 2
Supplement 3
Abstract Allergic asthma results from an uncontrolled type 2 immune response to inhaled allergens. Here, we investigate the function of CD97/ADGRE5, expressed in mouse and human immune and lung epithelial cells, in this disease. Female Cd97−/− mice exhibit an exacerbated asthmatic phenotype across multiple models, primarily due to CD97 loss on immune cells. A single CD97 antibody treatment before allergen sensitization worsens allergic responses, highlighting a role for CD97 in early immune regulation. Post-sensitization, Cd97−/− mice display higher frequencies of lung conventional type 2 and monocyte-derived dendritic cells (DCs). Allergen-pulsed Cd97−/− bone marrow-derived DCs are more activated, promote enhanced proliferation and type 2 cytokine secretion by CD4⁺ OT-II cells, and induce stronger airway inflammation. Consistently, ADGRE5 expression is reduced in airway mucosa-derived mononuclear phagocyte subsets in human asthmatics after allergen-induced exacerbation. These results identify CD97 as an important regulator of DC-driven type 2 allergic responses and a potential target in asthma.
Aust, G., Hoh, A.-L., Alladina, J., Smith, N.P., Höhna, F., Wang, B., Kerner, C., Wagner, M., Krohn, K., Pierzchalski, A., Häussler, N., Villani, A.C., Cho, J.L., Medoff, B.D., Zenclussen, A.C., Steinert, M., Hamann, J., Quaas, M., Polte, T. (2026):
CD97/ADGRE5 attenuates the induction of adaptive type 2 immune responses in allergic asthma
Nat. Commun. 17 , art. 9226
10.1038/s41467-026-76948-9